Advanced Search

902 KAR 55:115. Drug possession by hospice or home health agency


Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
      902 KAR 55:115. Drug possession by

hospice or home health agency.

 

      RELATES TO: KRS 217.005-217.215,

217.992

      STATUTORY AUTHORITY: KRS 194A.050,

211.090, 217.125, 315.300

      NECESSITY, FUNCTION, AND CONFORMITY:

KRS 315.300 authorizes the Cabinet for Health Services to promulgate administrative

regulations that implement the possession of certain drugs by a hospice or home

health agency. The purpose of this administrative regulation is to establish

criteria that a pharmacy, hospice or home health agency must meet in order to

insure that drugs belonging to a pharmacy, that are stored in a hospice or home

health agency, are safe and effective for administration to patients.

 

      Section 1. Authorized Employees. A

pharmacy may place a legend drug listed in KRS 315.300 with an authorized

employee of a hospice or a home health agency if the pharmacy maintains a record

of the license that authorizes the employee to administer legend drugs.

 

      Section 2. Written Agreement. Each

party to a written agreement between a pharmacy and a home health agency or a

pharmacy and a hospice shall maintain a copy of the written agreement.

 

      Section 3. Protocol. (1) A protocol

required by KRS 315.300 may be included in the written agreement or may be a

separate document.

      (2) If the protocol is a separate

document, a copy shall be maintained by the pharmacy and by the hospice or home

health agency.

      (3) The protocol shall be reviewed

not less than annually and modified if necessary.

 

      Section 4. Records. (1) The pharmacy

record of a drug placed with authorized employees of a hospice or home health

agency shall be retained for five (5) years.

      (2) The record of a drug administered

by authorized employees of a hospice or home health agency shall be retained by

the pharmacy for five (5) years. (25 Ky.R. 723; Am. 1369; eff. 12-16-98.)